한국지질동맥경화학회 학술대회

This session provides an in-depth exploration of the paradigm shift in obesity management from treatment to prevention. Prof. Choon Young Kim (Yeungnam University, Republic of Korea) presents the anti-obesity effects of bioactive compounds from natural products, focusing on cellular signaling and metabolic regulation. Prof. Yun Kyung Cho (University of Ulsan, Republic of Korea) discusses the therapeutic potential of semaglutide in obesity and its cardiometabolic benefits. Prof. Sang-Ho Jo (Hallym University, Republic of Korea) addresses the role of tirzepatide, a dual GIP/GLP-1 receptor agonist, in obesity treatment and comprehensive metabolic care.

The Journal of Lipid and Atherosclerosis (JLA) Committee has selected five outstanding papers published over the past year for presentation in this session. The authors will share key findings from their research on lipid metabolism and cardiovascular risk. Professor Su Youn Nam explores the association between high-density lipoprotein cholesterol and hematologic malignancy risk, while Professor Mee Kyoung Kim discusses the role of kidney function in cholesterol-related cardiovascular risk in type 2 diabetes. Professors Hayato Tada and Wen-Liang Song present on the impact of lipoprotein(a) on coronary artery disease and fibrinolysis, respectively, and Professor Belen Davico addresses the role of fatty acids in childhood obesity and cardiovascular risk. This session offers timely insights into the evolving understanding of lipid-related mechanisms in cardiometabolic diseases.